Blackstone Inc. – Consensus Indicates Potential 23.1% Upside

DirectorsTalk Interviews

Blackstone Inc. found using ticker (BX) have now 12 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 135 and 102 calculating the mean target price we have 119.33. Given that the stocks previous close was at 96.9 this is indicating there is a potential upside of 23.1%. There is a 50 day moving average of 98.98 and the 200 day moving average is 113.63. The company has a market cap of $119,998m. Visit the company website at: https://www.blackstone.com

The potential market cap would be $147,774m based on the market concensus.

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services. The real estate segment specializes in opportunistic, core+ investments as well as debt investment opportunities collateralized by commercial real estate, and stabilized income-oriented commercial real estate across North America, Europe and Asia. The firm’s corporate private equity business pursues transactions throughout the world across a variety of transaction types, including large buyouts,special situations, distressed mortgage loans, mid-cap buyouts, buy and build platforms, which involves multiple acquisitions behind a single management team and platform, and growth equity/development projects involving significant majority stakes in portfolio companies and minority investments in operating companies, shipping, real estate, corporate or consumer loans, and alternative energy greenfield development projects in energy and power, property, dislocated markets, shipping opportunities, financial institution breakups, re-insurance, and improving freight mobility, financial services, healthcare, life sciences, enterprise tech and consumer, as well as consumer technologies. The firm considers investment in Asia and Latin America. It has a three year investment period. Its hedge fund business manages a broad range of commingled and customized fund solutions and its credit business focuses on loans, and securities of non-investment grade companies spread across the capital structure including senior debt, subordinated debt, preferred stock and common equity. Blackstone Inc. was founded in 1985 and is headquartered in New York, New York with additional offices across Asia, Europe and North America.

Share on:
Find more news, interviews, share price & company profile here for:

    Likewise granted approval for 20,000 sq ft expansion of Newport facility

    Likewise Group has received planning permission to extend its Newport warehouse by 20,000 sq ft, creating a 55,000 sq ft distribution hub. The development will be funded through internal cash flow.

    Cerillion secures £17.3m follow-on contracts with major European customer

    Cerillion has signed two agreements worth a combined £17.3 million with an existing European customer, following an £8 million services contract announced in May 2025.

    Avation reports US$110m revenue and strengthened balance sheet for FY25

    Avation expects revenue of around US$110 million for the year to 30 June 2025. The company has reduced outstanding bond debt to US$298 million through repurchases and improved its credit ratings with Moody’s and Fitch.

    JPMorgan European Discovery Trust reports strong performance uplift in latest factsheet

    JPMorgan European Discovery Trust reported a 5.37% share price rise in July 2025, outpacing NAV and its benchmark. Year-to-date, the share price is up 34.17%, supported by strong small-cap performance and effective stock selection.

    Golden Matrix reports record August revenue of $17.8m, up 18% year-on-year

    Golden Matrix posted record August revenues of $17.8m, up 18% from last year, with July revenues also rising 24% to $15.7m. Strong performance came from Meridianbet’s sports betting and RKings’ tournaments, positioning the group for record Q3 results.

    HUTCHMED to present new lung cancer and oncology data at WCLC and CSCO 2025

    HUTCHMED announced that updated data on savolitinib in NSCLC and other pipeline compounds will be presented at the World Conference on Lung Cancer in Barcelona and the CSCO Annual Meeting in China this September. Presentations include studies on savolitinib, surufatinib, fruquintinib and first-in-human results for HMPL-653.

      Search

      Search